Pharmahungary Group as a Hungarian SME is ready to join Horizon Europe grant applications with innovative preclinical and clinical R&D services.
Highly Cited Researcher’ for the 5th time and elected as Editor-in-Chief of British Journal of Pharmacology
Up to 20 analysis available for researchers from April 6, 2022
Update from COVIRNA project – European Health Management Association session
Péter Ferdinandy, MD, PhD, MBA, Founder & CEO of Pharmahungary Group has been noticed as ‘Highly Cited Researcher’ for the 4th time